|
C2ORF68 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.057300E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.279600E-03 |
| Normal-vs-Stage2 |
8.067900E-02 |
| Normal-vs-Stage3 |
3.632100E-02 |
| Normal-vs-Stage4 |
6.038000E-02 |
| Stage1-vs-Stage2 |
7.951400E-01 |
| Stage1-vs-Stage3 |
8.865000E-01 |
| Stage1-vs-Stage4 |
7.424000E-01 |
| Stage2-vs-Stage3 |
7.534800E-01 |
| Stage2-vs-Stage4 |
6.666800E-01 |
| Stage3-vs-Stage4 |
8.619000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.877800E-03 |
| Normal-vs-AfricanAmerican |
1.485440E-01 |
| Normal-vs-Asian |
1.87769999999698E-05 |
| Caucasian-vs-AfricanAmerican |
7.427600E-01 |
| Caucasian-vs-Asian |
2.341600E-02 |
| AfricanAmerican-vs-Asian |
1.290140E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.009800E-02 |
| Normal-vs-Female |
6.03059999999545E-05 |
| Male-vs-Female |
6.821500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.053000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.175700E-04 |
| Normal-vs-Age(61-80Yrs) |
4.596300E-02 |
| Normal-vs-Age(81-100Yrs) |
4.445200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.145200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.614600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.026200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.074200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.798800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.127200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.25729999999902E-05 |
| Normal-vs-Grade 2 |
5.985000E-04 |
| Normal-vs-Grade 3 |
1.823820E-02 |
| Normal-vs-Grade 4 |
5.339600E-01 |
| Grade 1-vs-Grade 2 |
1.323170E-01 |
| Grade 1-vs-Grade 3 |
2.416000E-02 |
| Grade 1-vs-Grade 4 |
4.016900E-03 |
| Grade 2-vs-Grade 3 |
1.975000E-01 |
| Grade 2-vs-Grade 4 |
2.364400E-02 |
| Grade 3-vs-Grade 4 |
2.098800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.55179999966815E-07 |
| Normal-vs-ccB subtype |
7.497600E-01 |
| ccA subtype-vs-ccB subtype |
4.34689999995186E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.897070E-03 |
| Normal-vs-N1 |
6.304400E-01 |
| N0-vs-N1 |
4.118000E-01 |
|
|
